U.S. Capital Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
U.S. Capital Wealth Advisors's AMGN Position: Q1 2026 in Review
U.S. Capital Wealth Advisors increased its Amgen (AMGN) stake by 4.2% in Q1 2026, buying an estimated $300K and bringing the position to 20,942 shares worth $7.37M. The position accounts for 0.19% of the portfolio, ranked #128.
U.S. Capital Wealth Advisors first reported a position in AMGN in Q3 2021 and has held it in 19 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- U.S. Capital Wealth Advisors held 20,942 shares of Amgen worth $7.37M as of Q1 2026.
- U.S. Capital Wealth Advisors bought 841 Amgen shares in Q1 2026, an estimated $300K.
- Amgen made up 0.19% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #128 holding.
- U.S. Capital Wealth Advisors first reported a position in Amgen in Q3 2021 and has held it in 19 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.